The Belgian Competition Authority imposes a fine of €29.8M on a subsidiary and pharmaceutical wholesaler on account of participation in an alleged cartel between 2003 and 2016 (McKesson / Pharma Belgium-Belmedis)

The Belgian Competition Authority (BCA) announced today that it imposed a fine of EUR 29.8 million on McKesson subsidiary and pharmaceutical wholesaler Pharma Belgium-Belmedis (PBB) on account of that firm’s

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Van Bael & Bellis (Brussels)
  • Van Bael & Bellis (Brussels)
  • Van Bael & Bellis (Brussels)
  • Van Bael & Bellis (Brussels)

Quotation

Michael Clancy, Peter L'Ecluse, Catherine Longeval, Koen T'Syen, The Belgian Competition Authority imposes a fine of €29.8M on a subsidiary and pharmaceutical wholesaler on account of participation in an alleged cartel between 2003 and 2016 (McKesson / Pharma Belgium-Belmedis), 18 February 2022, e-Competitions February 2022, Art. N° 105388

Visites 282

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues